Department of Internal Medical Sciences, Faculty of Medicine, Ankara University, Ankara, Turkey.
Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine,Ankara University, Ankara, Turkey.
Turk J Med Sci. 2021 Oct;51(5):2690-2697. doi: 10.3906/sag-2101-116. Epub 2021 Oct 21.
High mobility group box- 1 (HMGB- 1) is a nuclear protein acting as a proinflammatory molecule. The serum HMGB- 1 levels were found elevated in chronic inflammatory diseases. In this cross-sectional study, serum HMGB- 1 levels in Behcet's disease (BD) patients and healthy controls (HC) were studied. Also, its association with disease activity scores and clinical findings were evaluated.
Ninety BD patients and 50 age-sex matched HC were included in the study. Disease activity scores were assessed by Behcet Disease Current Activity Form (BDCAF) and Behcet Syndrome Activity Score (BSAS). Serum HMGB- 1 levels were measured using a commercial ELISA kit. A p value of < 0.05 was considered to be statistically significant.
Serum HMGB- 1 levels were significantly higher in BD than in HC (43.26 pg/mL and 16.73 pg/mL; p < 0.001, respectively). Serum HMGB- 1 levels were statistically significantly associated with presence of erythema nodosum (EN) and genital ulcers in the last one month prior to recruitment (p = 0.041 and p < 0.001, respectively). BDCAF and BSAS scores were positively correlated with serum HMGB- 1 level ( p = 0.03 and p = 0.02, respectively).
HMGB - 1 may play a role in the development of BD. Also, due to its positive correlation with disease activity indices, it can be used as a novel disease activity parameter in BD.
高迁移率族蛋白 B1(HMGB-1)是一种核蛋白,作为一种促炎分子。在慢性炎症性疾病中发现血清 HMGB-1 水平升高。在这项横断面研究中,研究了 Behcet 病(BD)患者和健康对照者(HC)的血清 HMGB-1 水平,并评估了其与疾病活动评分和临床发现的关系。
纳入 90 例 BD 患者和 50 例年龄性别匹配的 HC。采用 Behcet 疾病活动表(BDCAF)和 Behcet 综合征活动评分(BSAS)评估疾病活动评分。使用商业 ELISA 试剂盒测量血清 HMGB-1 水平。p 值<0.05 被认为具有统计学意义。
BD 患者血清 HMGB-1 水平明显高于 HC(分别为 43.26 pg/ml 和 16.73 pg/ml;p<0.001)。血清 HMGB-1 水平与招募前一个月内存在结节性红斑(EN)和生殖器溃疡呈统计学显著相关(p=0.041 和 p<0.001,分别)。BDCAF 和 BSAS 评分与血清 HMGB-1 水平呈正相关(p=0.03 和 p=0.02,分别)。
HMGB-1 可能在 BD 的发病机制中起作用。此外,由于其与疾病活动指数呈正相关,因此可作为 BD 的新型疾病活动参数。